WAUKESHA, WI -- GE Healthcare showcased the company's pioneering new single photon emission computed tomography (SPECT) imaging applications; positron emission tomography/computed tomography (PET/CT) MotionFree technologies; and new pre-clinical imaging and radiopharmaceutical offerings at the 55th annual meeting of the Society of Nuclear Medicine. Rounding out GE Healthcare's presence was an Innovation Center that showcased future generation imaging technologies.

"SNM 2008 is a great opportunity to show GE's complete package of molecular imaging innovations," said Gene Saragnese, vice president of GE Healthcare's molecular imaging and CT business. "From imaging agents to future imaging technologies, GE Healthcare provides the industry's most comprehensive portfolio of clinically-relevant offerings."

At SNM 2008, GE Healthcare featured SPECT/CT, PET/CT, radiopharmacy and pre-clinical technologies that address some of the biggest issues facing healthcare providers, such as inaccuracy caused by motion in PET/CT imaging, the need for better visualization of disease and efficient workflow in SPECT/CT, faster throughput for pre-clinical imaging and more consistent and compliant imaging agent production in radiopharmaceuticals.
"Molecular imaging innovations are key to realizing GE Healthcare's vision for an Early Health model of care," said Jean-Luc Vanderheyden, global molecular imaging leader for GE Healthcare. "Our focus is to deliver on the initiative of Early Health-moving our healthcare system from being reactive - when diseases are diagnosed late and could be more difficult to treat, to proactive- possibly preventing disease before it happens with early diagnosis and accurate follow-up."

"We are focused on advancing the field of molecular imaging to help clinicians see disease earlier than ever before," said Vanderheyden. "That's the idea of Early Health, and it's the very basis of molecular imaging. It truly is a revolution in healthcare, and we are asking everyone to be a part of it."

SPECT/CT

GE launched two breakthrough software packages on the company's flagship 4-slice SPECT/CT, the Infinia Hawkeye 4. The new Volumetrix Suite consists of two powerful applications that deliver image clarity and diagnostic confidence with precise detection and localization of disease, the Volumetrix 3D and Volumetrix IR. Volumetrix 3D brings together the convenience of advanced 3D visualization with the productivity and ease of traditional 2D image analysis. Volumetrix IR offers a clinician the choice of virtually any CT to view registered to the SPECT data, all within the nuclear medicine workflow.

More Industry Headlines